| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Baek | 20 | 0% |
| Examiner Craig | 11 | 0% |
| Examiner Dickinson | 326 | 53% |
| Examiner Donohue | 277 | 35% |
| Examiner Hartley (SPE) | 13 | 23% |
| Examiner Jones | 261 | 66% |
| Examiner Mejias | 9 | 0% |
| Examiner Perreira | 258 | 65% |
| Examiner Rogers | 319 | 52% |
| Examiner Samala | 338 | 75% |
| Examiner Schlientz | 199 | 50% |
| Examiner Vu | 267 | 27% |
| Examiner Westerberg | 275 | 20% |
| Examiner Young | 341 | 60% |
| Art Unit 1618 | 2914 | 50% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 514 | Drug, bio-affecting and body treating compositions |
| 600 | Surgery |
| 604 | Surgery |
| 534 | Organic compounds -- part of the class 532-570 series |
| 376 | Induced nuclear reactions: processes, systems, and elements |
| 435 | Chemistry: molecular biology and microbiology |
| 606 | Surgery |
| 506 | Combinatorial chemistry technology: method, library, apparatus |
| 436 | Chemistry: analytical and immunological testing |
Art Unit 1618's grant rate is lower than that of Group 1610 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1618, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.